Microsoft Pri0
Welcome to Microsoft Pri0: That's Microspeak for top priority, and that's the news and observations you'll find here from Seattle Times reporter Sharon Chan.
November 7, 2007 5:18 PM
Potential rival to Enbrel on the horizon
Posted by Angel Gonzalez
An experimental arthritis therapy known as golimumab showed promising results in a late-stage clinical study for the treatment of psoriatic arthritis, Johnson & Johnson unit Centocor and Schering-Plough said Wednesday. The data signals the potential appearance of a new rival to Enbrel, the best-selling treatment developed in Seattle by Immunex and now sold by Amgen.
The compound is designed to be administered less frequently than Enbrel and Abbott Laboratories' Humira (one injection a month, instead of one a week for Enbrel and one every two weeks for Humira). The therapy constitutes an "incremental improvement" over Enbrel and other similar drugs, said Dr. Philip Mease, chief of the Swedish Medical Center's Division of Rheumathology Research in Seattle. Dr. Mease served as an investigator in the trial.
Jul 1, 08 - 11:45 AM
Microsoft buying natural-language search company Powerset
Jun 30, 08 - 05:16 PM
Report: Microsoft to cut Xbox 360 price ahead of big industry event
Jun 27, 08 - 03:52 PM
Gates send-off: Gates has had Ballmer's back from the beginning
Jun 27, 08 - 01:09 PM
Gates send-off: Photos
Jun 27, 08 - 11:48 AM
Gates send-off: Two guys and 90,000 employees

nwjobs

Post a comment

Michelle Goodman blogs about work/life balance.
How to tell your office you're gravely ill
Post a comment
nwautos

Choosing a new sedan? Weigh the impact of your choice on your wallet and on the planet.
Post a comment

- Flags were key link to cop slaying, bombings
- Suspect shot as city mourns slain officer
- Bombs, guns found at home of suspect in Officer Brenton's slaying
- Briefs | Soccer: New Mexico suspends hair-pulling player Elizabeth Lambert
- How an underdog named Mike McGinn took City Hall
- Huskies suffer another heartbreaking loss to UCLA
- 3 Cascade Mountain passes close due to snow; more rain, wind expected Sunday
- McGinn pulling away as late ballots come in
- Using anti-shooter tactics, civilian Army police officer brought down gunman
- The birth of 'Grunge,' in photos by Michael Lavine
- Suspect shot as city mourns slain officer
- Flags were key link to cop slaying, bombings
- The birth of 'Grunge,' in photos by Michael Lavine
- 10 investing missteps to avoid
- How do innovators think?
- 10 ways to take control of your health
- Bombs, guns found at home of suspect in Officer Brenton's slaying
- Danny Westneat | Lee the Horse Logger found slow wagon shrank tumor
- Tlingit heritage helps glass artist Preston Singletary break new ground
- How an underdog named Mike McGinn took City Hall

July
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 |
Bill Gates, who last week ended his full-time involvement with Microsoft, was often right. He made a career, a company and an industry by looking over the horizon.






